Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ADG126 |
Trade Name | |
Synonyms | ADG-126|ADG 126 |
Drug Descriptions |
ADG126 is a monoclonal antibody that binds to and inhibits CTLA-4 expressed on T lymphocytes, potentially leading to enhanced antitumor immune response (J Clin Oncol 40, no. 16_suppl (June 01, 2022) e17601-e17601). |
DrugClasses | CTLA4 Antibody 31 Immune Checkpoint Inhibitor 149 |
CAS Registry Number | NA |
NCIT ID | C179276 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ADG106 + ADG126 | ADG106 ADG126 | 0 | 1 |
ADG126 | ADG126 | 0 | 2 |
ADG126 + unspecified PD-1 antibody | ADG126 unspecified PD-1 antibody | 0 | 1 |